抽象的

Recombinant Protein Production Advances in Mammalian Cell

Artuna Jessi


The lapse of blockbuster biologics has additionally prodded the development of biosimilars. The expanding quantities of trailblazer biologic items and biosimilars have consequently fuelled the interest in the creation of cell lines with high usefulness. Right now, mammalian cell line advancement advances utilized by most biopharmaceutical organizations depend on either the methotrexate (MTX) intensification innovation or the glutamine synthetase (GS) framework. With the two frameworks, the cell clones acquired are profoundly heterogeneous, because of irregular genome reconciliation by the quality of interest and the quality intensification measure. Subsequently, enormous quantities of cell clones must be screened to distinguish uncommon stable high maker cell clones. Thusly, the phone line improvement measure ordinarily expects 6 to a year and is a period, capital and work concentrated interaction.


免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证

索引于

  • 中国社会科学院
  • 谷歌学术
  • 打开 J 门
  • 中国知网(CNKI)
  • 引用因子
  • 宇宙IF
  • 电子期刊图书馆
  • 研究期刊索引目录 (DRJI)
  • 秘密搜索引擎实验室
  • ICMJE

查看更多

期刊国际标准号

期刊 h 指数

Flyer